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SUMMARY 
Background: Stroke is an emerging public health chal-
lenge in Ghana requiring urgent attention for its con-
trol. Because some of the risk factors for stroke are 
modifiable, characterisation of these risk factors in the 
Ghanaian population as well as outcomes of stroke are 
urgently needed to guide policy for non-communicable 
diseases. We therefore conducted this study to evaluate 
the frequencies of the traditional risk factors and out-
comes of stroke at the main tertiary referral centre in 
the middle belt of Ghana in a prospective observational 
study.  
Methods and results: Patients with a clinical diagno-
sis of stroke were consecutively recruited and vascular 
risk factors were assessed as well as markers of severi-
ty of stroke and in-patient treatment outcomes. 265 
patients were recruited, 56.6% were females and mean 
± SD age of 64.6 ± 14.54 years. 85%, 73% and 58% of 
patients had systemic arterial hypertension, physical 
inactivity and obesity respectively as common risk 
factors. We identified that patients with stroke had a 
median of 3 traditional risk factors, were unaware of 
the presence of these risk factors or were poorly con-
trolled if known. Stroke was associated with a high in-
patient case fatality rate of 43% principally among pa-
tients with haemorrhagic stroke.  
Conclusions: Our findings indicate that urgent con-
certed efforts are required to improve public awareness 
and management of the prevailing risk factors of stroke 
in Ghana.  
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INTRODUCTION 
Stroke is the third leading cause of mortality world-
wide and global estimates of disease burden projects 
that within the next two decades it will continue to rank 
among the top four causes of death even within devel-
oping countries.1 A review of stroke epidemiology over 
the last four decades has suggested that while the inci-
dence of stroke is on the decline in most developed 
countries through improved awareness and manage-
ment of risk factors, that of developing countries con-
tinues to increase with a nearly 100% increment for 
some low-income countries.2 Furthermore nearly two-
thirds of stroke case fatalities occur in resource-limited 
settings where infrastructure is lacking to provide the 
requisite support for stroke patients. 
 
Because the annual cost of stroke –amounting to some 
$ 65.5 billion in 2008 in the US alone 3 is beyond the 
reach of most developing countries, whose limited 
health resources are being stretched to meet the health 
needs imposed by infections such as malaria, HIV and 
tuberculosis, there is an urgent need for attention to be 
focused on the prevention of the catastrophic conse-
quences of vascular diseases such as stroke. Among the 
secondary prevention strategies for stroke advocated by 
the World Health Organisation, emphasis is placed on 
intensified reduction in exposure to major cardiovascu-
lar risk factors.4  
 
However because the prevalence and characterisation 
of stroke risk factors in most Sub-Saharan countries 
such as Ghana remains largely unknown, resource allo-
cation and strategic planning for prevention continues 
to be met with difficulties. Thus in the present study we 
describe the profile of risk factors, clinical types and 
characterise the factors associated with stroke in-
patient mortality at Komfo Anokye Teaching Hospital, 
the second largest tertiary referral centre in Ghana. 
 
METHODS 
Ethics statement: The study was approved by and con-
formed to the ethical guidelines of the Committee on 
Human Research Publications and Ethics of the School 
of Medical Sciences of the Kwame Nkrumah Universi-
ty of Science and Technology and the Komfo Anokye 
Teaching Hospital, ref number: CHRPE/01/10.  
 
 






After a thorough explanation of the research protocol 
in the local dialect, written informed consent was ob-
tained either from conscious patients or their first-
degree relatives for patients with depressed level of 
consciousness by signing or thumb-printing depending 
on literacy status.  
 
This study was an observational prospective study 
where consecutive patients aged >15 years with a case 
definition of stroke were eligible for enrollment. The 
minimum criteria for a definite or probable stroke di-
agnosis include evidence of sudden or rapid onset of 
neurological symptoms lasting > 24 hours or leading to 
death in the absence of evidence for a non-stroke cause 
according to the WHO clinical definition of stroke. 
6Patient’s socio-demographic information, history and 
clinical examination findings with emphasis on cardio-
vascular risk factors for stroke and outcomes were cap-
tured on a study questionnaire. Routine haematology 
and fasting biochemistry were performed within 48 
hours of admission.  
 
The following definitions and techniques were used to 
identify risk factors for stroke in each patient: 
1. Hypertension was defined as systolic blood 
pressure ≥ 140 mm Hg or diastolic pressure ≥ 
90 mm Hg persisting > 7 days after the acute 
event (World Health Organization classifica-
tion) or pre-stroke treatment with antihyper-
tensive drugs. 7 
2. Diabetes mellitus was defined as a previous 
diagnosis of type I or II diabetes, at least 2 
random blood glucose readings of ≥ 11.1 
mmol/l, or a fasting blood glucose reading of 
≥ 7 mmol/l after the acute phase of stroke to 
exclude acute transient elevation of glucose as 
a stress response after stroke.8 
3. Hypercholesterolemia was defined as serum 
cholesterol of > 5.2 mmol/l or pre-stroke 
treatment with a cholesterol-lowering agent. 9 
4. Raised body mass index was defined as > 27 
kg/m2 in ambulant patients or waist circum-
ference of > 80cm in females and > 94cm in 
males. Waist circumference was measured by 
using a tape measure horizontally placed at 
the level of the superior crests and ensuring 
that the tape measure was snug and did not 
compress the skin. Measurement was made at 
the end of normal expiration.10 
5. Current smoking status and alcohol intake sta-
tus was ascertained from either the patient or a 
reliable relative. A high alcohol intake was de-
fined as ≥ 14 U per week for women, ≥ 21 U 
per week for men. 
6. An ECG and/or an echocardiogram were per-
formed in patients with suspected cardio-
embolic stroke. 
7. Physical activity status of participants was as-
sessed using the International Physical Activi-
ty Questionnaire. For participants who were 
either aphasic or unconscious their relatives 
were questioned on patients’ physical activity 
status. Responders who reported spending 
more than half the day on their feet or were 
involved in daily exercises were classified as 
physically active. Those who spent less than 
half of the day on their feet or led a sedentary 
life were classed as physically inactive as has 
previously been applied.10 
 
The classification of the pathologic type of stroke into 
cerebral ischaemia or primary intracerebral haemor-
rhage was based on results from brain imaging with a 
computed tomography scan or the Siriraj stroke 
score.11The validity of the Siriraj stroke score was as-
sessed by determining its sensitivity, specificity and 
positive predictive accuracy among patients who had 
CT scan of the brain performed.  
 
The National Institute of Health Stroke Scale was em-
ployed to determine the severity of stroke within 24h of 
admission. Patient autonomy and functional status be-
fore the onset of stroke were assessed with a modified 
Barthel Scale of Activities of Daily Living (m-ADL). 
The modification involved the replacement of “the 
ability to walk up and down stairs” with “the ability to 
reach household facilities in separate buildings”. The 
m-ADL scale was used retrospectively to document 
possible pre-stroke disabilities, and the Rankin Disabil-
ity Score was used to assess the functional status of 
stroke patients on the day of discharge. 
 
Statistical analysis: The data from the questionnaire 
were entered into a Microsoft excel (2003) sheet. De-
scriptive results of demographics and identifiable risk 
factors were presented as percentages. The student’s t-
test and the Mann-Whitney U-test were used to com-
pare means and medians respectively while the Fisher’s 
exact test was used to test for significance between 
observed associations. Associations between risk of 
death and clinical and laboratory parameters were ana-
lyzed using a multiple logistic regression modeling. In 
all analyses, a 2-tailed p-value less than 0.05 were con-
sidered significant. Statistical analyses were performed 
using the Graph Pad Prism 4 and multiple logistic re-













Demographic, clinical and diagnostic data:  
A total of 265 consecutive patients with clinical diag-
nosis of stroke were recruited. This included 115 males 
and 150 females with a slight preponderance of fe-
males with a female to male ratio of approximately 
1.3:1.0. The mean ± SD age of study participants was 
64.6 ± 14.54 years with a modal age range of 70 -79 
years. Approximately 60% of patients presented within 
24 hours after onset of stroke for management with the 
rest presenting within 2 – 14 days. 41% had right-sided 
weakness, 35% had left-sided weakness, 23% had bi-
lateral weakness while 1% had no motor weakness. 
The frequencies of other symptoms accompanying fo-
cal motor neurological deficit in study subjects were 
loss of speech (56%), depressed level of consciousness 
(44%), headaches (26%), seizures (9%), vomiting (8%) 
and a few presented with dizziness, palpitations, fever, 
restlessness or neck pains. 
 
Using the Siriraj stroke scoring scale, 43% of partici-
pants were classified as having ischaemic stroke, 39% 
had haemorrhagic stroke and 18% were equivocal. Of 
the 19 cranial CT scans performed in this study 10 pa-
tients had ischaemic strokes while the remainder had 
haemorrhagic strokes. In order to ascertain the accura-
cy of the Siriraj stroke score that was used to classify 
stroke type in a majority of study participants, the clin-
ical scoring scale was compared with CT scan results. 
This analysis revealed that all 10 lesions classified as 
ischaemic by the Siriraj stroke scale were subsequently 
confirmed on CT-scan. Furthermore 6 patients who had 
haemorrhagic stroke by the Siriraj stroke score were 
also found to have haemorrhagic strokes on CT scan 
but 3 patients with equivocal scores on the Siriraj 
stroke scoring scale had haemorrhagic strokes on CT 
scan. Thus the Siriraj stroke scoring scale had a sensi-
tivity of 100%, a specificity of 100% and positive pre-
dictive accuracy of 100% for cerebral infarction while 
that for intracerebral haemorrhage were 67%, 60% and 
100% respectively.  
 
The severity of stroke at presentation as assessed using 
the National Institute of Health Stroke Scale revealed a 
median (range) score of 16 (2-42). Finally the func-
tional status of patients before the onset of stroke was 
measured with the modified Barthel’s scale which 
showed a median score of 20/20 with a range of 6/20 – 
20/20).  
 
Traditional vascular risk factors of stroke: Systemic 
hypertension was the preponderant modifiable risk 
factor identified in 85% of stroke patients followed by 
physical inactivity (73%), obesity (58%), hypercholes-
terolemia (47%) and type 2 diabetes mellitus (38%) as 
shown in Table 1. Fifty-nine percent (59%), 15% and 
1% of participants were aware of the presence of hy-
pertension, diabetes mellitus and dyslipidaemia respec-
tively prior to the onset of stroke. Among patients with 
an awareness of the presence of vascular risk factors 
especially hypertension, 35% admitted to compliance 
with their medications, 52% were not compliant while 
compliance could not be assessed in 13% of study par-
ticipants (n=175). Reasons cited by stroke patients for 
their non-compliance included the use of herbal reme-
dies for cure of their vascular risk factors (59%), finan-
cial constraints (12%) while 22% gave no reasons but 
the remainder reported frequent travels, side effects of 
medications and the belief that they have been cured of 
hypertension after initial treatment with antihyperten-
sive. 
 
Hypercholesterolemia and obesity were significantly 
more prevalent among female subjects than male sub-
jects. Conversely male subjects were more significantly 
predisposed to heavy alcohol consumption and ciga-
rette smoking compared with female participants as 
shown in Table 1. Only 6% of strokes were attributable 
to probable cardio-embolic causes. Figure 1 depicts the 
risk factor profile per subject. The median cumulative 
number of modifiable traditional risk factors of stroke 
per patient was 3 (0 – 6).  
 
Table 1 The percentage frequency of the traditional 
risk factors of stroke among study subjects 









Hypertension 81  88  0.12 85 
Physical inactivity 70  76  0.13 73  
Obesity 33  76  0.0001 58  
Hypercholesterole-
mia 
33  58  0.003 47  
Diabetes mellitus 33  42  0.16 38  
Heavy alcohol con-
sumption 
34  7  0.0001 19  
Previous stroke 10  24  0.10 14 
Cigarette smoking 16  2  0.0001 8 
Atrial fibrillation 6  3 0.66 4 
Transient ischaemic 
attack 
1 1 1.0 2 
Congestive cardiac 
failure 
0 1 0.51 1 
Carotid artery steno-
sis 
0 1 0.26 1 
Intra-cardiac mural 
thrombus 
1 0  0.43 1 
 
The commonest combination of risk factors was hyper-
tension, hypercholesterolemia and physical inactivity. 
The 3 patients with no modifiable risk factors of stroke 
were all elderly male subjects.  
 
 






ECG was performed in 118 (45%) study subjects. 77 
(65%) had evidence of left ventricular hypertrophy 
according to the Sokolow’s criteria. 
 
In-patient outcomes of stroke:  
The median duration of hospitalisation was 6 days [In-
terquartile range (IQR), 4-9 days; range, 1-42 days]. 
Overall case fatality during hospitalisation was 43.4%; 
with fatality for ischaemic stroke being 17.5% and that 
for intra-cerebral haemorrhage of 70.2% (p=0.0001). 
Death occurred after a median of 5 days (IQR, 2-8 
days; range of 1-21 days). 35% of those who died had 
clinical evidence of aspiration pneumonitis. 
 
Table 2 Admission clinical and laboratory findings 
according to outcome of stroke 









172.8 ± 36.17 179.9 ± 40.75 0.13 
Diastolic blood 
pressure (mmHg) 
101.2 ± 20.56 107 ± 24.52 0.03 
Pulse rate 
(beats/min) 
84.3 ± 13.38 89.6 ± 15.30 0.003 
Glasgow coma 
score 
15 (3 -15) 9 (3 -15) <0.0001 
NIHSS 10 (2 – 32) 28 (2 – 42) <0.0001 
Blood Glucose 
(mmol/l) 
9.0 ± 4.93 10.6 ± 4.02 0.0065 
Total cholesterol 
(mmol/l) 
5.1 ± 1.43 5.4 ± 1.94 0.3 
HDL- cholesterol 
(mmol/l) 
1.3 ± 0.60 1.6 ± 0.88 0.003 
LDL-cholesterol 
(mmol/l) 
3.4 ± 1.60 4.0 ± 2.00 0.09 
Triglycerides 
(mmol/l) 
1.4 ± 0.66 1.5 ± 0.95 0.49 
Creatinine 
(µmol/l) 
118.9 ± 130.0 175.9 ± 234.9 0.02 
Urea (mmol/l) 7.2 ± 6.28 11.5 ± 13.35 0.003 
Uric acid 
(mmol/l) 
403.2 ± 180.7 545.9 ± 294.1 0.0004 
Haemoglobin 
(g/dl) 
13.1 ± 2.23 13.6 ± 2.27 0.08 
White cell count 
(x 109) 
8.1 ± 3.19 11.2 ± 4.84 <0.0001 
Platelet count (x 
109) 
210 ± 88.5 200 ± 97.4 0.44 
As shown in Table 2, blood glucose, urea, creatinine, 
serum uric acid, HDL-cholesterol and white cell count 
at admission were significantly higher in patients who 
died than those who survived. Furthermore patients 
who died had significantly depressed level of con-
sciousness, higher NIHSS, faster pulse rate and higher 
diastolic blood pressure than those who survived.  
 
 

















Number of risk factors per patient
 
Figure 1 Graph showing the cumulative number of 
modifiable risk factors per patient. 
 
A multivariate logistic regression analysis showed that 
the risk of death was significantly predicted by severity 
of stroke and hyperuricaemia (Table 3). Finally, among 
patients who were discharged a significant proportion 


















Table 3 Univariate and multivariate logistic regression analysis of clinical and laboratory parameters associated 
with in-patient mortality after stroke. 
 
1NIHSS- National Institute of Health Stroke Scale used to assess severity of stroke.  
2 Leukocytosis defined as WBC count > 10 x109.  
3 Elevated serum uric acid defined as fasting serum uric concentration >360mmol/l for females and >420mmol/l for males.
 
 














Rankin score at discharge  
Figure 2 Graph showing the Rankin score of function-






Stroke is a preventable cardiovascular disorder with 
well-recognised risk factors. The identification and 
appropriate modification of these risk factors are the 
targets of both primary and secondary preventive strat-
egies.12,14 The objective of this study was to describe 
the prevalence of the conventional risk factors, types 
and outcomes of stroke in Kumasi, Ghana. The main 
observations in the present study were the following: 
firstly, there was a high prevalence of hypertension 
(85%) overall among stroke patients in Ghana. Second-
ly stroke patients had a median of at least three modifi-
able risk factors, which were not been managed prior to 
the onset of stroke. Thirdly there was a high in-patient 
mortality of 43.4% together with severe functional lim-
itation among survivors upon discharge regardless of 
the type of stroke.  
 
Overall the demographics, risk factor profile and out-
comes of stroke in this study were comparable with 
other studies conducted in sub-Saharan Africa. Age is 
the strongest risk factor for both cerebral ischaemia and 
primary intracerebral haemorrhage. The incidence of 
stroke approximately doubles with each decade over 
the age of 55 years.15  
 
Variable Unadjusted odds 
ratio (95% CI) 
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The mean age of 64.6 years of the participants was 
higher than the 59.8 years previously reported about a 
decade ago in Accra, Ghana,16 60.4 years reported in 
Dakar, Senegal,17 58 years in a Gambian cohort,18 56 
years in Kano, Nigeria,19 55 years in Maiduguri (north-
eastern Nigeria)20 and 54 years in Ogun and Lagos 
states (South-western Nigeria)21 respectively.  
 
The slightly older age of stroke patients in this study 
than those reported in elsewhere in sub-Saharan Africa 
is probably a reflection of the gradually improving so-
cio-economic status of Ghanaians and other developing 
countries that are in a demographic transition. It is im-
portant to note that these cited studies were conducted 
either in the late 1990’s or early 2000’s. Indeed a re-
cent study conducted in Port Harcourt, Nigeria and 
published in 2009 for instance showed the mean age of 
stroke patients was 62.6 years.22  
 
Male gender is a risk factor for stroke overall, however 
due to their greater life expectancy and the greater im-
portance of age as a risk factor, more women will suf-
fer stroke during their lifetime. This observation was 
reflected in this study, as there was a preponderance of 
females over males with a ratio of 1.3:1.0, which was 
similarly observed in the Port Harcourt study22 where 
the female to male ratio was 1.2:1.0. However in a pre-
vious Ghanaian study, there has been a tendency for a 
slight male predominance.16  
 
Of the modifiable risk factors of stroke, systemic arte-
rial hypertension remains the most potent risk factor 
for stroke with a 7-fold relative risk compared with 
normotensives.23 Studies conducted in sub-Saharan 
Africa has consistently shown the importance of hyper-
tension as a risk factor for stroke19,20,24 and we show 
that although 85% of subjects were hypertensive, only 
59% were aware of the presence of hypertension with 
35% of hypertensive patients admitting to compliance 
to their medications prior to the onset of stroke. It is 
also interesting that non-compliance to therapy was 
largely attributed to the frequent use of herbal reme-
dies.  
 
Thus the escalation of stroke in developing countries 
may be attenuated by improved screening of the adult 
population for the presence of vascular risk factors 
through strengthening of public health educational pro-
grammes. Importantly, we also note that most patients 
had a median of 3 risk factors which required concur-
rent management, thus primary physicians involved in 
the care of patients should actively embark on a screen-
ing programme to identify all possible risk factors in 
their patients in order to maximise the benefit of risk 
factor modification. 
Using the Siriraj Stroke Scale (SSS) the frequency of 
ischaemic and haemorrhagic varieties of stroke in this 
study were 43% and 39% respectively in Kumasi, with 
the scoring system unable to classify the remaining 
18% of cases. A previous study conducted in Accra, 
Ghana by Obajimi et al. showed the prevalence of CT 
scan confirmed ischaemic and haemorrhagic strokes to 
be 47.1% and 52.9%16 respectively as has also been 
shown in Nigeria where Ogun et al. found that 49% of 
strokes in the Ogun state were accounted for by the 
ischaemic variety with 45% being haemorrhagic.25  
 
The use of a clinical scoring system for classifying 
stroke may have compromised the quality our analyses, 
however the SSS has been validated in resource - lim-
ited settings and has been shown to be accurate in clas-
sifying strokes. Its overall predictive accuracy com-
pared to the gold standard of CT scan was found to be 
90% in Bangkok, Thailand,11 80% in Southwest Nige-
ria 21 although one retrospective study reported a low 
predictive accuracy of 54% in the Ogun state.26 In this 
study we found the overall predictive accuracy of the 
SSS to be 100% with excellent sensitivity and specific-
ity for cerebral infarction and a somewhat reduced sen-
sitivity and specificity for intracerebral haemorrhage.  
 
The high mortality of stroke in sub-Sahara African 
studies is indicative of our unpreparedness for the 
stroke epidemic. In-patient case fatality rate in our se-
ries was 43.4%. At the Lagos University Teaching 
Hospital case fatality of stroke was 26% at 7 days, 
41.2% at 30 days and 86% at 6 months of incident 
stroke27,28 and this was similar to that in the Ogun state 
of 28%, 40% and 46% respectively. 25 Similarly 1-
month mortality after stroke was 38% in Dakar (Sene-
gal),17 27% in the Gambia,18 and 29.3% in Maurita-
nia.29 Indeed it is now believed that two-thirds of stroke 
mortality world-wide occur in developing countries30,31 
and is largely the result of inadequate infrastructure 
and delayed presentation of patients to health centres 
for management.  
 
Even though 60% of stroke patients presented within 
24 hours of ictus, a significant proportion had severe 
strokes, which undoubtedly impacted on stroke out-
comes. In a multivariate logistic regression, death after 
stroke in this cohort was independently associated with 
the severity of stroke and hyperuricaemia at presenta-
tion on adjusted analysis (Table 3). The observed asso-
ciation between hyperuricaemia and risk of death is 
particularly interesting because there is ongoing debate 
on whether uric acid is protective 32 or has adverse 
prognostic consequences33,34 after a stroke with our 
data in support of the later hypothesis.  
 
 






Further studies are required to explore the prognostic 




In conclusion, our study shows that stroke is associated 
with unacceptably high in-patient mortality and pa-
tients have multiple risk factors requiring modification. 
Taken together the most cost-effective approach for the 
management of stroke in sub-Saharan Africa would be 
improved public health education directed at better 
awareness of risk factors and their management to pre-
vent strokes while making concerted efforts at setting 
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